Universität zu Köln

Journal Article

Baunwall, Simon Mark Dahl, Terveer, Elisabeth M., Dahlerup, Jens Frederik, Erikstrup, Christian ORCID: 0000-0001-6551-6647, Arkkila, Perttu, Vehreschild, Maria J. G. T., Ianiro, Gianluca, Gasbarrini, Antonio ORCID: 0000-0003-4863-6924, Sokol, Harry, Kump, Patrizia K., Satokari, Reetta, De Looze, Danny, Vermeire, Severine ORCID: 0000-0001-9942-3019, Nakov, Radislav, Brezina, Jan, Helms, Morten, Kjeldsen, Jens ORCID: 0000-0001-8148-6572, Rode, Anne A., Kousgaard, Sabrina Just ORCID: 0000-0002-2394-7104, Alric, Laurent, Trang-Poisson, Caroline, Scanzi, Julien, Link, Alexander, Stallmach, Andreas, Kupcinskas, Juozas, Johnsen, Peter Holger, Garborg, Kjetil, Rodriguez, Eugenia Sanchez, Serrander, Lena, Brummer, Robert J., Galperine, Katerina Tatiana, Goldenberg, Simon D., Mullish, Benjamin H., Williams, Horace Rt, Iqbal, Tariq H., Ponsioen, Cyriel, Kuijper, Ed J., Cammarota, Giovanni ORCID: 0000-0002-3626-6148, Keller, Josbert J. and Hvas, Christian Lodberg (2021). The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey. Lancet Reg. Health-Eur., 9. AMSTERDAM: ELSEVIER. ISSN 2666-7762

Cornely, Oliver A., Watt, Maureen, McCrea, Charles, Goldenberg, Simon D. and De Nigris, Enrico (2018). Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients aged >= 60 years (EXTEND): analysis of cost-effectiveness. J. Antimicrob. Chemother., 73 (9). S. 2529 - 2540. OXFORD: OXFORD UNIV PRESS. ISSN 1460-2091

Guery, Benoit, Menichetti, Francesco, Anttila, Veli-Jukka, Adomakoh, Nicholas, Aguado, Jose Maria, Bisnauthsing, Karen, Georgopali, Areti, Goldenberg, Simon D., Karas, Andreas, Kazeem, Gbenga, Longshaw, Chris, Alejandro Palacios-Fabrega, Jose, Cornely, Oliver A. and Vehreschild, Maria J. G. T. (2018). Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial. Lancet Infect. Dis., 18 (3). S. 296 - 308. OXFORD: ELSEVIER SCI LTD. ISSN 1474-4457

Keller, Josbert J., Ooijevaar, Rogier E., Hvas, Christian L., Terveer, Elisabeth M., Lieberknecht, Simone C., Hogenauer, Christoph ORCID: 0000-0003-4566-0806, Arkkila, Perttu, Sokol, Harry, Gridnyev, Oleksiy ORCID: 0000-0003-4716-3520, Megraud, Francis ORCID: 0000-0002-2481-1612, Kump, Patrizia K., Nakov, Radislav, Goldenberg, Simon D., Satokari, Reetta, Tkatch, Sergiy, Sanguinetti, Maurizio ORCID: 0000-0002-9780-7059, Cammarota, Giovanni ORCID: 0000-0002-3626-6148, Dorofeev, Andrey, Gubska, Olena, Laniro, Gianluca, Mattila, Eero, Arasaradnam, Ramesh P., Sarin, Shiv K., Sood, Ajit, Putignani, Lorenza ORCID: 0000-0003-0134-2830, Alric, Laurent, Baunwall, Simon M. D., Kupcinskas, Juozas, Link, Alexander ORCID: 0000-0002-9514-4562, Goorhuis, Abraham G., Verspaget, Hein W., Ponsioen, Cyriel, Hold, Georgina L., Tilg, Herbert, Kassam, Zain, Kuijper, Ed J., Gasbarrini, Antonio ORCID: 0000-0003-4863-6924, Mulder, Chris J. J., Williams, Horace R. T. and Vehreschild, Maria J. G. T. (2021). A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group. United European Gastroenterol. J., 9 (2). S. 229 - 248. THOUSAND OAKS: SAGE PUBLICATIONS INC. ISSN 2050-6414

Keller, Josbert J., Vehreschild, Maria J. G. T., Hvas, Christian L., Jorgensen, Simon M. D., Kupcinskas, Juozas, Link, Alexander ORCID: 0000-0002-9514-4562, Mulder, Chris J. J., Goldenberg, Simon D., Arasaradnam, Ramesh ORCID: 0000-0002-2231-3062, Sokol, Harry, Gasbarrini, Antonio, Hoegenauer, Christoph, Terveer, Elizabeth M., Kuijper, Ed J. and Arkkila, Perttu (2020). Donated stool for faecal microbiota transplantation is not a drug, but guidance and regulation are needed. United European Gastroenterol. J., 8 (3). S. 353 - 355. THOUSAND OAKS: SAGE PUBLICATIONS INC. ISSN 2050-6414

Vehreschild, Maria J. G. T., Taori, Surabhi ORCID: 0000-0002-2976-4106, Goldenberg, Simon D., Thalhammer, Florian, Bouza, Emilio ORCID: 0000-0001-6967-9267, van Oene, Joop, Wetherill, Graham and Georgopali, Areti (2018). Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE). Eur. J. Clin. Microbiol. Infect. Dis., 37 (11). S. 2097 - 2107. NEW YORK: SPRINGER. ISSN 1435-4373